These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23909033)

  • 1. [Effectiveness of mammary scintigraphy for determining the results of neoadjuvant polychemotherapy in breast cancer].
    Kanaev SV; Krivorot'ko PV; Novikov SN; Semiglazov VF; Semiglzova TIu; Turkevich EA; Zhukova LA; Klimashevskiĭ VF; Ivantsov AO; Donskikh RV; Klimenko VV; Briantseva ZhV
    Vopr Onkol; 2013; 59(3):328-33. PubMed ID: 23909033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of scintimammography with 99mTs-technetril to predict the pathologic status of regional lymph nodes in patients with locally advanced breast cancer after neoadjuvant chemotherapy].
    Bryantseva ZhV; Kanaev SV; Semiglazov VF; Novikov SN; Krivorotko PV; Klimenko VV; Trufanova ES; Kotova ZS; Chernaya AV; Turkevich EA; Semiglazova TY
    Vopr Onkol; 2015; 61(2):185-8. PubMed ID: 26087595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
    Portnoĭ SM; Odzharova AA; Shiriaev SV; Anurova OA; Laktionov KP; Riabchikov DA
    Vopr Onkol; 2006; 52(6):620-3. PubMed ID: 17338237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of mammoscintigraphy results in breast cancer patients receiving neoadjuvant polychemotherapy].
    Kanaev SV; Novikov SN; Krivorotko PV; Semiglazova TY; Chernaya AV; Turkevich EA; Bryantseva ZV
    Vopr Onkol; 2016; 62(4):479-84. PubMed ID: 30475533
    [No Abstract]   [Full Text] [Related]  

  • 5. High pathologic complete response in HER 2-positive locally advanced breast cancer after primary systemic chemotherapy with weekly docetaxel and epirubicin.
    Chen SC; Chang HK; Lin YC; Hsueh S; Cheung YC; Leung WM; Tsai CS; Lo YF; Tsai HP; Shen SC; Chen MF
    Jpn J Clin Oncol; 2008 Feb; 38(2):99-105. PubMed ID: 18270380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
    Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
    Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
    Sciuto R; Pasqualoni R; Bergomi S; Petrilli G; Vici P; Belli F; Botti C; Mottolese M; Maini CL
    J Nucl Med; 2002 Jun; 43(6):745-51. PubMed ID: 12050317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.
    Amioka A; Masumoto N; Gouda N; Kajitani K; Shigematsu H; Emi A; Kadoya T; Okada M
    Jpn J Clin Oncol; 2016 Apr; 46(4):303-9. PubMed ID: 26848078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
    Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
    Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response.
    Travaini LL; Baio SM; Cremonesi M; De Cicco C; Ferrari M; Trifirò G; Prisco G; Viale G; Colleoni MA; Radice D; Sivolapenko GB; Paganelli G
    Breast; 2007 Jun; 16(3):262-70. PubMed ID: 17291755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer.
    Dumanskiy YV; Bondar OV; Stoliarchuk EA
    Exp Oncol; 2019 Jun; 41(2):176-178. PubMed ID: 31262151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S
    Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance and specifics of surgical treatment in locally advanced breast cancer].
    Ostapenko V; Ostapenko A
    Vopr Onkol; 2011; 57(5):578-83. PubMed ID: 22238926
    [No Abstract]   [Full Text] [Related]  

  • 16. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the effectiveness of various comprehensive treatments for locally advanced breast cancer].
    Kharchenko VP; Khmelevskiĭ EV; Panyshin GA
    Vopr Onkol; 1998; 44(4):443-6. PubMed ID: 9807210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.